ID21547A - Kristal-kristal dari turunan benzimidazol dan produksinya - Google Patents

Kristal-kristal dari turunan benzimidazol dan produksinya

Info

Publication number
ID21547A
ID21547A IDW990304A ID990304A ID21547A ID 21547 A ID21547 A ID 21547A ID W990304 A IDW990304 A ID W990304A ID 990304 A ID990304 A ID 990304A ID 21547 A ID21547 A ID 21547A
Authority
ID
Indonesia
Prior art keywords
substituted
optionally
benzimidazol
derives
crystals
Prior art date
Application number
IDW990304A
Other languages
English (en)
Inventor
Masayasu Kato
Toru Ishida
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17920069&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID21547(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of ID21547A publication Critical patent/ID21547A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IDW990304A 1996-11-14 1997-11-13 Kristal-kristal dari turunan benzimidazol dan produksinya ID21547A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP30336196 1996-11-14

Publications (1)

Publication Number Publication Date
ID21547A true ID21547A (id) 1999-06-24

Family

ID=17920069

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW990304A ID21547A (id) 1996-11-14 1997-11-13 Kristal-kristal dari turunan benzimidazol dan produksinya

Country Status (18)

Country Link
US (1) US6002011A (id)
EP (1) EP0944617B1 (id)
KR (1) KR100519576B1 (id)
CN (2) CN100355749C (id)
AT (1) ATE240314T1 (id)
AU (1) AU731776B2 (id)
CA (1) CA2269053C (id)
DE (1) DE69722027T2 (id)
DK (1) DK0944617T3 (id)
ES (1) ES2199356T3 (id)
ID (1) ID21547A (id)
IL (1) IL129724A (id)
NZ (1) NZ335145A (id)
PT (1) PT944617E (id)
TR (1) TR199901055T2 (id)
TW (1) TW385306B (id)
WO (1) WO1998021201A1 (id)
ZA (1) ZA9710255B (id)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW385306B (en) * 1996-11-14 2000-03-21 Takeda Chemical Industries Ltd Method for producing crystals of benzimidazole derivatives
IL142703A (en) 1998-11-10 2006-04-10 Astrazeneca Ab Crystalline form of omeprazole
UA72748C2 (en) 1998-11-10 2005-04-15 Astrazeneca Ab A novel crystalline form of omeprazole
JP3926936B2 (ja) 1998-11-16 2007-06-06 エーザイ・アール・アンド・ディー・マネジメント株式会社 スルホキシド誘導体・アセトン錯体およびその製造法
DE50012015D1 (de) * 1999-02-04 2006-03-30 Joern Bullerdiek Mittel zur prävention und/oder behandlung einer gewebeveränderung mesenchymalen ursprungs
US7110444B1 (en) 1999-08-04 2006-09-19 Parkervision, Inc. Wireless local area network (WLAN) using universal frequency translation technology including multi-phase embodiments and circuit implementations
TWI275587B (en) 1999-06-17 2007-03-11 Takeda Chemical Industries Ltd A crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
PL333847A1 (en) * 1999-06-18 2001-01-02 Inst Farmaceutyczny Crystalline forms of lansoprozole and method of obtaining lansoprazole in pharmacologically advanthageous crystalline form
ATE298334T1 (de) 1999-06-30 2005-07-15 Takeda Pharmaceutical Kristalle von lansoprazole
EP1897877B1 (en) 2000-05-15 2014-09-24 Takeda Pharmaceutical Company Limited Crystalline forms of (R)-lanzoprazole
AU2001276721A1 (en) * 2000-08-04 2002-02-18 Takeda Chemical Industries Ltd. Salts of benzimidazole compound and use thereof
EP1310252A4 (en) 2000-08-18 2009-06-10 Takeda Pharmaceutical INJECTIONS
PL399787A1 (pl) 2000-12-01 2012-11-05 Takeda Pharmaceutical Company Ltd. Krysztaly (R)- lub (S)-2-[[[3-metylo-4-(2,2,2-trifluoroetoksy)-2-pirydynylo]metylo]sulfinylo]-1H-benzimidazolu, kompozycja farmaceutyczna zawierajaca te krysztaly i ich zastosowanie
DE10140492A1 (de) 2001-08-17 2003-08-14 Gruenenthal Gmbh Hydrate von gegebenenfalls substituierten 2-(2-Pyridinyl)methylthio-1H-benzimidazolen und Verfahren zu ihrer Herstellung
EP1459737B1 (en) 2001-10-17 2012-09-26 Takeda Pharmaceutical Company Limited Granules containing acid-unstable chemical in large amount
KR20090045419A (ko) * 2002-02-19 2009-05-07 테바 파마슈티컬 인더스트리즈 리미티드 아토르바스타틴 헤미-칼슘 용매화합물의 탈용매화
JP2005533755A (ja) * 2002-03-27 2005-11-10 テバ ファーマシューティカル インダストリーズ リミティド ランソプラゾール多形及びその調製方法
KR100873419B1 (ko) * 2002-06-18 2008-12-11 페어차일드코리아반도체 주식회사 높은 항복 전압, 낮은 온 저항 및 작은 스위칭 손실을갖는 전력용 반도체 소자
TW200410955A (en) 2002-07-29 2004-07-01 Altana Pharma Ag Novel salt of (S)-PANTOPRAZOLE
ES2294358T3 (es) 2002-08-21 2008-04-01 Teva Pharmaceutical Industries Ltd Procedimiento de purificacion de lansoprazol.
EP1764364A1 (en) * 2002-08-21 2007-03-21 Teva Pharmaceutical Industries Ltd A method for the purification of lansoprazole
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
AU2003273000A1 (en) 2002-10-16 2004-05-04 Takeda Pharmaceutical Company Limited Stable solid preparations
EP1743893A1 (en) 2002-11-18 2007-01-17 Teva Pharmaceutical Industries Ltd. Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol
AU2003294405A1 (en) * 2002-11-18 2004-06-15 Teva Pharmaceutical Industries Ltd. Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol
JP2006516574A (ja) * 2003-02-05 2006-07-06 テバ ファーマシューティカル インダストリーズ リミティド ランソプラゾール安定化方法
US7005732B2 (en) * 2003-10-21 2006-02-28 Honeywell International Inc. Methods and systems for providing MEMS devices with a top cap and upper sense plate
TW200526268A (en) * 2003-12-17 2005-08-16 Takeda Pharmaceutical Injectable composition
SE0400410D0 (sv) * 2004-02-20 2004-02-20 Astrazeneca Ab New compounds
CA2570916C (en) 2004-06-16 2013-06-11 Tap Pharmaceutical Products, Inc. Pulsed release dosage form of a ppi
CN102775388B (zh) 2004-09-13 2016-01-20 武田药品工业株式会社 氧化化合物的制备方法和制备装置
EP1681056A1 (en) * 2005-01-14 2006-07-19 Krka Tovarna Zdravil, D.D., Novo Mesto Process for preparing lansoprazole
ES2675581T3 (es) 2005-02-25 2018-07-11 Takeda Pharmaceutical Company Limited Método para producir gránulos de un compuesto de bencimidazol recubiertos
US20090030044A1 (en) * 2005-06-07 2009-01-29 Takeda Pharmaceutical Company Limited Crystal of Salt of Benzimidazole Compound
US20090036406A1 (en) * 2005-06-13 2009-02-05 Takeda Pharmaceutical Company Limited Injection
ZA200805646B (en) 2005-12-28 2009-12-30 Takeda Pharmaceutical Controlled release solid preparation
KR100758600B1 (ko) * 2006-01-05 2007-09-13 주식회사 대웅제약 란소프라졸 결정형 ａ의 제조방법
WO2008035189A1 (en) * 2006-09-22 2008-03-27 Orchid Chemicals & Pharmaceuticals Limited A method for the purification of lansoprazole
EP2089379A4 (en) * 2006-12-07 2010-04-21 Hetero Drugs Ltd NEW CRYSTALLINE SHAPE OF LANSOPRAZOLE
ITMI20062481A1 (it) * 2006-12-22 2008-06-23 Recordati Chem Pharm Processo per la preparazione di lansoprazolo forma i microcristallino
JP5366558B2 (ja) 2006-12-28 2013-12-11 武田薬品工業株式会社 口腔内崩壊性固形製剤
CA2676477A1 (en) * 2007-12-31 2009-07-16 Takeda Pharmaceutical Company Limited Crystalline solvated forms of (r)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazole
CN102026994B (zh) * 2008-03-10 2014-05-07 武田药品工业株式会社 苯并咪唑化合物的晶体
WO2011004387A2 (en) 2009-06-18 2011-01-13 Matrix Laboratories Ltd Process for the preparation of dexlansoprazole polymorphic forms
US20130012714A1 (en) * 2010-02-11 2013-01-10 Orchid Chemicals & Pharmaceuticals Limited Novel solvate of dexlansoprazole
PE20140005A1 (es) 2010-12-03 2014-01-23 Takeda Pharmaceutical Tableta oralmente desintegradora
SG10201602311XA (en) 2010-12-27 2016-04-28 Takeda Pharmaceutical Orally disintegrating tablet
CN103012369B (zh) * 2011-05-23 2014-04-23 中山大学 兰索拉唑n晶型及其制备方法和应用
CN102180866B (zh) * 2011-05-23 2013-03-13 中山大学 兰索拉唑晶型及其制备方法和应用
TWI630002B (zh) 2011-11-30 2018-07-21 武田藥品工業股份有限公司 乾塗覆錠
US9119769B2 (en) 2011-12-30 2015-09-01 The Curators Of The University Of Missouri Method for transforming pharmaceutical crystal forms
MY184077A (en) 2013-05-21 2021-03-17 Takeda Pharmaceuticals Co Orally disintegrable tablet
CN103539728A (zh) * 2013-10-14 2014-01-29 安徽国星生物化学有限公司 一种拉唑类药物中间体氯甲基吡啶衍生物的合成方法
CN103539729A (zh) * 2013-10-14 2014-01-29 安徽国星生物化学有限公司 一种氯甲基吡啶衍生物的工业化生产方法
CN104829594A (zh) * 2015-05-15 2015-08-12 苗怡文 一种治疗胃溃疡的药物兰索拉唑化合物
CN104817492B (zh) * 2015-05-22 2018-05-18 抚州三和医药化工有限公司 兰索拉唑中间体2-羟甲基-3-甲基-4-(2,2,2-三氟乙氧基）吡啶的分离纯化方法
KR102649498B1 (ko) 2023-12-06 2024-03-20 거산해운(주) 선사별 실시간 통합 예약 정보를 기반으로 한 화주의 해상 운송 예약 자동화 플랫폼 서비스 제공 방법, 장치 및 시스템

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
DK171989B1 (da) * 1987-08-04 1997-09-08 Takeda Chemical Industries Ltd Fremgangsmåde til fremstilling af 2-(2-pyridylmethylsulfinyl)-benzimidazoler
DE4018642C2 (de) * 1990-06-11 1993-11-25 Byk Gulden Lomberg Chem Fab Neue Salzform des 5-Difluormethoxy-2-[(3,4-dimethoxy-2-pyridyl) methylsulfinyl]-1H-benzimitazol-Natriumsalzes
SE9302395D0 (sv) * 1993-07-09 1993-07-09 Ab Astra New pharmaceutical formulation
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
US5374730A (en) * 1993-11-04 1994-12-20 Torcan Chemical Ltd. Preparation of omeprazole and lansoprazole
GB2297550B (en) * 1995-02-06 1997-04-09 Smithkline Beecham Plc Paroxetine hydrochloride anhydrate substantially free of bound organic solvent
TW385306B (en) * 1996-11-14 2000-03-21 Takeda Chemical Industries Ltd Method for producing crystals of benzimidazole derivatives

Also Published As

Publication number Publication date
IL129724A0 (en) 2000-02-29
ATE240314T1 (de) 2003-05-15
DE69722027D1 (de) 2003-06-18
EP0944617A1 (en) 1999-09-29
EP0944617B1 (en) 2003-05-14
HK1020194A1 (en) 2000-03-31
PT944617E (pt) 2003-08-29
ES2199356T3 (es) 2004-02-16
CN1616457A (zh) 2005-05-18
DK0944617T3 (da) 2003-09-01
WO1998021201A1 (en) 1998-05-22
US6002011A (en) 1999-12-14
AU731776B2 (en) 2001-04-05
TW385306B (en) 2000-03-21
ZA9710255B (en) 1999-05-13
NZ335145A (en) 2000-12-22
DE69722027T2 (de) 2004-03-25
CN1171885C (zh) 2004-10-20
TR199901055T2 (xx) 1999-07-21
IL129724A (en) 2004-02-19
CA2269053C (en) 2006-07-18
AU4965297A (en) 1998-06-03
CN100355749C (zh) 2007-12-19
KR100519576B1 (ko) 2005-10-07
CA2269053A1 (en) 1998-05-22
KR20000053158A (ko) 2000-08-25
CN1237167A (zh) 1999-12-01

Similar Documents

Publication Publication Date Title
ID21547A (id) Kristal-kristal dari turunan benzimidazol dan produksinya
HUP9802859A2 (hu) Acil-amino-szalicilsav-amid-származékok és alkalmazásuk peszticidként
DE69534975D1 (de) Verwendung von noribogain derivaten zur behandlung von chemischer abhängigkeit bei säugern
PL328726A1 (en) Novel tricycle compounds, method of obtaining them and their applications
HRP990167B1 (en) Sulphinic acid derivatives, method for producing them, and their use
DK0696281T3 (da) Hidtil ukendte 5-pyrrolyl-2-pyridylmethylsulfinylbenzimidazolderivater
EA200200510A1 (ru) 4-карбоксиамино-2-этил-1,2,3,4-тетрагидрохинолин в кристаллической форме как ингибитор сетр
MY100665A (en) 7-carboxymethoxy-furo-(3,4-c)-pyridine derivatives.
SE8107273L (sv) 2-oxoazetidinderivat, sett att framstella democh anvendning derav
KR850003719A (ko) 시아노피라졸 제초제에 대한 개량
DE3778714D1 (de) Indenothiazolderivate und verfahren zu ihrer herstellung.
MY109628A (en) An improved proces for the preparation of substituted indoline derivatives
DE69614841D1 (de) Verfahren zur Herstellung von Galanthaminderivate durch asymmetrische Reduktion
BG103271A (en) Derivatives of n-(benzothiazol-2-yl) piperidine-1-ethaneamines, method for their preparation and application as therapeutical means
EP0449195A3 (en) Aminobenzene compounds, their production and use
NO941073L (no) Fenylglycinamid av heterocykliske, substituerte fenyleddiksyrederivater
DE69518252D1 (de) Verfahren zur herstellung von 5,6-dihydroxy-2-amino-1,2,3,4-tetrahydronaphthalin-derivaten
PT99280A (pt) Processo de preparacao de derivados do indolo e de composicoes farmaceuticas
HUP0003024A2 (hu) Eljárás nitro-guanidin-származékok előállítására és az új kiindulási vegyületek
ID21677A (id) Proses pembuatan n-[2-(dimetilamino)etil]-akridin-4-karboksamida
ATE144900T1 (de) Verwendung von xanthinderivaten gegen magengeschwüre
CO4940468A1 (es) Nuevos derivados de naftilpiperacina
ATE67194T1 (de) Thiadiazolylacetamid-derivate, verfahren zu ihrer herstellung und ihre verwendung.
HUT39173A (en) Process for production of derivatives of 3-hydro-amino-2,3-dihydro-benzoxepin
KR860008142A (ko) 피라졸리디늄 일리드의 제조방법